Section 2011 - Congressional declaration of policy

4 Analyses of this statute by attorneys

  1. Proposed Bill Would Provide Grants to Local Communities and Change Decommissioning Process

    Morgan Lewis - Up & AtomPaul BessetteSeptember 25, 2020

    The NRC, however, does not formally approve (or reject) PSDARs. The bill would change this by amending the Atomic Energy Act of 1954 (42 USC § 2011 et seq.) to add Section 113, “Post-Shutdown Decommissioning Activities Reports.”

  2. Senate adopts Iran Nuclear Agreement Review Act

    Dentons LLPPeter FeldmanMay 13, 2015

    The P5+1 comprises China, France, Germany, Russia, the United Kingdom and the United States. The Act amends the Atomic Energy Act of 1954 (42 USC 2011 et seq.) by adding new Section 135. Although it is the six countries of the P5+1 that are negotiating an agreement with Iran, the Act defines "agreement" to be any agreement that makes commitments on the US, not commitments on the P5+1.

  3. Framework for Nuclear Agreement with Iran Announced—But Still a Long Way to Go

    Pillsbury Winthrop Shaw Pittman LLPStephan BeckerApril 27, 2015

    Other secondary sanctions, as well as “primary” sanctions imposed on U.S. companies under U.S. sanctions regulations and Executive Orders, would remain in place.Impact on Nuclear Negotiations with Other Countries One area where the Framework Agreement may have an impact is with respect to other nuclear non-proliferation efforts and negotiations. The Framework Agreement may have implications for the negotiation of some civil nuclear cooperation agreements that the U.S. is currently negotiating with other countries, commonly referred to as “123 Agreements” after section 123 of the Atomic Energy Act, 42 U.S.C. § 2011, et seq., which governs the transfer of certain nuclear materials and reactor equipment. The extent to which the Framework Agreement may impact future 123 Agreement negotiations is yet to be determined.Path to U.S. Approval and Lingering Questions Ultimately, much work remains to be done for the P5+1 countries and Iran to reach a final agreement, and a number of other obstacles to such an accord exist.

  4. President Signs Genetic Information Nondiscrimination Act into Law

    Stark & StarkMay 21, 2008

    at are commercially and publicly available (including newspapers, magazines, periodicals, and books, but not including medical databases or court records) that include family medical history; (5) where the information involved is to be used for genetic monitoring of the biological effects of toxic substances in the workplace, but only if– (A) the employer provides written notice of the genetic monitoring to the employee; (B)(i) the employee provides prior, knowing, voluntary, and written authorization; or (ii) the genetic monitoring is required by Federal or State law; (C) the employee is informed of individual monitoring results; (D) the monitoring is in compliance with– (i) any Federal genetic monitoring regulations, including any such regulations that may be promulgated by the Secretary of Labor pursuant to the Occupational Safety and Health Act of 1970 (29 U.S.C. 651 et seq.), the Federal Mine Safety and Health Act of 1977 (30 U.S.C. 801 et seq.), or the Atomic Energy Act of 1954 (42 U.S.C. 2011 et seq.); or (ii) State genetic monitoring regulations, in the case of a State that is implementing genetic monitoring regulations under the authority of the Occupational Safety and Health Act of 1970 (29 U.S.C. 651 et seq.); and (E) the employer, excluding any licensed health care professional or board certified genetic counselor that is involved in the genetic monitoring program, receives the results of the monitoring only in aggregate terms that do not disclose the identity of specific employees; or (6) where the employer conducts DNA analysis for law enforcement purposes as a forensic laboratory or for purposes of human remains identification, and requests or requires genetic information of such employer’s employees, but only to the extent that such genetic information is used for analysis of DNA identification markers for quality control to detect sample contamination. (c) Preservation of Protections- In the case of information to which any of paragraphs (1) through (6) of subse